课题基金 / 基金详情

Alternative targets for treating cancer

Alternative targets for treating cancer
治疗癌症的替代目标
批准号:
nhmrc : GNT1057742
负责人:
A/Pr Christopher Burns
金额:
$71.7万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-01-01 至 --

项目摘要

项目成果

A/Pr Christopher Burns的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer cells are often sustained by evading cell death. Thus, a promising approach to develop new cancer treatments aims to restore their ability to commit cell suicide. Proteins related to Bcl-2 are, in this regard, attractive targets because they are prominent barriers to cell death. This project seeks to uncover how a Bcl-2 relative, Mcl-1, is regulated, and to explore how the mechanisms that underpin these processes can be targeted in cancers (melanomas, leukemias) that it sustains.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding ligand binding within the insulin-like growth factor family with direct application to cancer therapeutic design
Understanding ligand binding within the insulin-like growth factor family with direct application to cancer therapeutic design
  • 批准号:
    nhmrc : GNT1128553
  • 项目类别:
    Project Grants
  • 资助金额:
    $86.12万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Christopher Burns
  • 依托单位:
Targeting an epigenetic pathway to treat asthma
Targeting an epigenetic pathway to treat asthma
  • 批准号:
    nhmrc : GNT1100451
  • 项目类别:
    Project Grants
  • 资助金额:
    $44.41万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Christopher Burns
  • 依托单位:
国内基金
海外基金
miR-29a "targets" PPAR δ对心力衰竭的作用及作为潜在标志物的研究
  • 批准号:
    81371895
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    臧明玺
  • 依托单位: